Literature DB >> 2833851

Comparison of immunoperoxidase and DNA in situ hybridization techniques in the diagnosis of cytomegalovirus colitis.

S S Robey1, W R Gage, F P Kuhajda.   

Abstract

Cytomegalovirus (CMV) infection of the colon occurs in immunocompromised patients and in patients with ulcerative colitis. In the former, it can cause serious bleeding or colonic perforation and in the latter, it may precipitate a fulminant phase of illness. The authors compared the immunoperoxidase technique with a monoclonal antibody (Mab) against CMV early antigen and DNA in situ hybridization using a biotinylated probe in the identification of virus-infected cells in colon samples from patients with known CMV colitis and with fulminant ulcerative colitis without histologic evidence of infection. The Mab stained the nuclei of infected cells without recognizable viral inclusions particularly in cases showing few characteristic viral inclusions. In well-developed CMV infections, with many inclusions, immunoperoxidase staining was less prominent. The biotinylated DNA probe recognized cytopathic cells with prominent inclusions but was only rarely positive in smaller cells. In specimens with few inclusions, there was no staining with in situ hybridization. No positivity was observed by either technique in cases of fulminant ulcerative colitis with no morphologic evidence of CMV infection. The authors conclude that immunoperoxidase using monoclonal anti-CMV early antigen adds useful information in the evaluation of early or focal cases of CMV colitis. DNA in situ hybridization is usually positive in cytopathic cells and is less useful for diagnosis. CMV could not be demonstrated in cases of fulminant ulcerative colitis when viral inclusions were not observed in routine preparations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833851     DOI: 10.1093/ajcp/89.5.666

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  16 in total

1.  DNA viruses in the pathogenesis of sporadic chronic idiopathic intestinal pseudo-obstruction.

Authors:  H S Debinski; M A Kamm; I C Talbot; G Khan; H O Kangro; D J Jeffries
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

2.  Cytomegalovirus colitis in an elderly patient.

Authors:  S H Jawad
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

3.  Cytomegalovirus adrenalitis in acquired immunodeficiency syndrome.

Authors:  Brian Chiu; Jack Butany; Kaiman Kovacs; Zi Cheng
Journal:  Endocr Pathol       Date:  1994-12       Impact factor: 3.943

Review 4.  Cytomegalovirus and inflammatory bowel disease: is there a link?

Authors:  Valeria Criscuoli; Maria-Rosa Rizzuto; Mario Cottone
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

5.  Gold induced enterocolitis complicated by cytomegalovirus infection: a previously unrecognised association.

Authors:  V Wong; J Wyatt; F Lewis; P Howdle
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

6.  Cytomegalovirus-associated colitis causing diarrhea in an immunocompetent patient.

Authors:  Dan Carter; David Olchovsky; Russell Pokroy; David Ezra
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

7.  Cytomegalovirus detection by biotinylated DNA probes.

Authors:  S M Qadri; M N Al-Ahdal; S G Qadri; G Y Khan
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

8.  Cytomegalovirus infection in gastrointestinal tracts of patients infected with HIV-1 or AIDS.

Authors:  N D Francis; A W Boylston; A H Roberts; J M Parkin; A J Pinching
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

9.  The diagnosis of anal ulcers in AIDS patients.

Authors:  S M Cohen; S L Schmitt; F V Lucas; S D Wexner
Journal:  Int J Colorectal Dis       Date:  1994       Impact factor: 2.571

10.  Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  Elena Garrido; Elisa Carrera; Rebeca Manzano; Antonio Lopez-Sanroman
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.